https://pubmed.ncbi.nlm.nih.gov/8869390/
Double-blind study of the activity and tolerability of cabergoline versus placebo in parkinsonians...
The use of a dopamine agonist with a long duration of action has theoretical advantages in attempting to reduce the motor fluctuations in Parkinson's disease....